Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Michael Lasser

Is Dollar Tree Stock a Buy, Hold or Sell After Earnings?

Dollar Tree stock is higher Wednesday after the retailer beat Q3 earnings expectations and updated its full-year outlook. Here's what Wall Street has to say.

Kiplinger

The Analyst Landscape: 39 Takes On Walmart

Throughout the last three months, 39 analysts have evaluated Walmart (NYSE:WMT), offering a diverse set of opinions from bullish to bearish.

Benzinga

Dollar Tree Stock Sinks As "Macro Pressures" Impact Consumer Spending

Dollar Tree stock is plunging Wednesday after the discount retailer missed Q2 expectations and slashed its full-year outlook. Here's what you need to know.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Walmart's shopper surge last quarter should boost retailer's profits for the rest of the year

On its latest earnings call, Walmart beat expectations and raised its guidance for the rest of the year.

Fortune

Forget GameStop, Here's the Old-School Retail Stock Analysts Are Betting On

After its well-received earnings report, analysts at UBS upgraded Best Buy, predicting more upside ahead for the big-box retailer.

Barchart

Here's Why Best Buy Stock Could Rally Another 17%

Best Buy stock could continue to rally thanks to several positive catalysts and a leaner operating model, UBS says. Here's what you need to know.

Kiplinger

Why You Should Consider Buying the Dip in This Dividend King

Despite investor concerns over price cuts, here’s why investors should consider buying this Dividend King on the dip.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Retailers are facing ‘shrink’ from an increasing ‘organized retail crime’ threat—but UBS says it won’t last

The recent influx of organized retail crime is coming to its natural end, and retailers like Target and Walmart will benefit, UBS says.

Fortune

Celebrity weight loss jab to be available on WeightWatchers

WeightWatchers has acquired telehealth provider Sequence that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity

The Independent UK

WeightWatchers gets into prescription weight loss business

WeightWatchers' stock is soaring after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.